GTBP Stock Analysis: Buy, Sell, or Hold?
GTBP - GT Biopharma Inc. Common Stock
$0.66
-0.02 (-2.93%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 20, 2026
19d
Get Alerted When GTBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GTBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GTBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GTBP is currently trading at $0.66, which is considered slightly low relative to its 30-day fair value range of $0.69 to $0.81.
Technical Outlook: Technically, GTBP is showing sideways momentum. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GTBP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+1076.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GTBP is showing sideways momentum. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GTBP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+1076.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.69 -
$0.81
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding GTBP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1076.5% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-7.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.69 -
$0.81
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$0.78
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-0.97
Wall Street Target
$8.00
(+1076.5%)
Last updated: January 31, 2026 11:24 AM ET
Data refreshes hourly during market hours. Next update: 12:24 PM
Data refreshes hourly during market hours. Next update: 12:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GTBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
MRNA
Moderna Inc |
SELL
27 analysts |
$38 | 59 HOLD |
Advanced GTBP Option Strategies
Professional options setups generated by AI based on today's GTBP price and gamma walls.
